Un listing de conférences scientifiques et techniques

Accueil | Logiciel de gestion de conférence | Calendrier des conférences | Annonces publicitaires | Nous contacter | Qui nous sommes
Deutsch Français English
Vous êtes ici: AccueilCalendrier des conférencesSoins de santé → Pharmacologie et développement des médicaments - États-Unis
Advances in Cell Based Assays
Cuescience – Live-Streaming war noch nie so einfach.
Social Media in the Pharmaceutical Industry

Logiciel de gestion de conférences

Notre système de gestion de conférences en ligne (COMS) vous permet de:

  • gérer l'organisation de la conférence en ligne
  • gérer les inscriptions
  • gérer les paiements
  • gérer les soumissions de présentations
  • gérer la procédure de revue
  • sélectionner les présentations
  • produire le livre des résumés

Pour en savoir plus ...

Conférences - Pharmacologie et développement des médicaments - États-Unis met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

 Dates 05 Oct 2015 → 06 Oct 2015
[ID=723864] Haut de la page
 LieuJersey City, États-Unis
 Résumé This annual Alzheimer's Drug Discovery Foundation (ADDF) conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunities for collaboration and partnering.
 Sujets Alzheimer's, dementia, drug discovery
 Page web
 Contact Sara Classen; Tél.: [(212)901-8009]; Email.:
 Sujets apparentés Neurologie
2.SOS-2015 — Science of Stability Conference 2015
 Dates 12 Oct 2015 → 14 Oct 2015
[ID=728988] Haut de la page
 LieuGroton, États-Unis
 Résumé Establishing and improving the shelf-life of pharmaceuticals, nutraceuticals and other consumer goods is critical for taking product development to the next level. Despite this, fundamental aspects of Stability Science still remain mysterious to many. Join us to learn about the very latest findings from Industry and Academia. While most Stability Conferences focus on regulations and requirements; here at SOS-2015 "It's all about the Science."
 Sujets stability, drug stability, stability science, science of stability, its all about the science, pharmaceutical stability, Latest theories on the role of moisture and temperature on chemical reactions in solids, Use of in silico modeling for degradation mechanisms, Recent findings in oxidation chemistry related to peroxides, Amorphous dispersion, Use of accelerated stability for formulation development
 Page web
 Contact Elise Napper; Tél.: [+1.860.237.5800]; Email.:
3.AMS USA 2015 — World Anti-Microbial Congress USA 2015
 Dates 19 Oct 2015 → 20 Oct 2015
[ID=726444] Haut de la page
 LieuWashington, DC, États-Unis
 Résumé The World AntiMicrobial Resistance Congress USA gathers key stakeholders from government, funding agencies, pharma, academia and payers to discuss the urgent need for new antibiotics. President Obama has outlined his 5-year action plan to fight AMR and is seeking to double the AMR funding to $1.2B, but the bigger challenge is how to deliver these actions.This 2-day conference presents solutions through key notes, case study presentations, expert opinion and roundtable discussions, and invites key influencers such as BARDA, NIH, FDA, grant agencies, pharma and academia, in the AMR discussion. This is the 2-day exhibition and conference you cannot afford to miss.
 Sujets Private funding for antibiotic research, Generating an antimicrobial from natural products using a molecular approach, Genome mining to achieve novel antibiotic research, screening membrane-active compounds for antibiotic efficacy, and many more
 Page web &utm_campaign=COMS Listing
 Contact Freya Smale; Tél.: [646-619-1811]; Email.:
4.Antibody Drug Conjugates Conference
 Dates 22 Oct 2015 → 23 Oct 2015
[ID=717310] Haut de la page
 LieuBoston, États-Unis
 Résumé We invite you to attend the Antibody Drug Conjugates Conference, which will take place October 22-23, 2015 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics. With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
 Sujets I. Advances in Protein Modeling and Engineering Breakthroughs II. Novel Payloads and Linker Technology III. Pre-Clinical and Clinical Advances IV. Translational Considerations V. ADC Applications Beyond Oncology
 Page web
 Contact Kristen Starkey; Tél.: [626-256-6405]; Email.:
 Sujets apparentés Biotechnologie
5.3rd Antibody & Protein Therapeutics Conference
 Dates 22 Oct 2015 → 23 Oct 2015
[ID=717375] Haut de la page
 LieuBoston, États-Unis
 Résumé We welcome you to the 3rd Antibody & Protein Therapeutics Conference, which will be held October 22-23, 2015 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development. Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics including antibody drug conjugates, bispecific antibodies, antibody combinations, and check point inhibiting antibodies. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment!
 Sujets I. Advances in Protein Modeling and Engineering Breakthroughs II. Therapeutic Applications of Antibodies & Proteins III. Novel Bispecific and Multispecific Antibodies & Proteins IV. Preclinical Development and Clinical Trials V. New Target Identification Methods
 Page web
 Contact Kristen Starkey; Tél.: [626-256-6405]; Email.:
 Sujets apparentés Biotechnologie
6.2015 American Association of Pharmaceutical Scientists Annual Meeting & Exposition
 Dates 25 Oct 2015 → 29 Oct 2015
[ID=699152] Haut de la page
 LieuOrlando, États-Unis
 Page web
7.2nd Annual Drug Discovery USA Congress
 Dates 29 Oct 2015 → 30 Oct 2015
[ID=718015] Haut de la page
 LieuBoston, États-Unis
 Résumé Oxford Global’s 2nd Annual Drug Discovery USA Congress brings together over 150 industry leaders to discuss recent developments in drug discovery and medicinal chemistry.
 Sujets drug discovery, GPCR, Ion channel, assay development, screening, flow cytometry, high content analysis, medicinal chemistry, PPI, Computational chemistry, discovery chemistry, synthtetic chemistry, drug design, cheminformatics, discovery data
 Page web
 Contact Guillaume Alonso; Tél.: [+44 (0)1865 248 455]; Email.:
 Sujets apparentés Chimie informatique
8.American Association for Laboratory Animal Science 66th National Meeting
 Dates 01 Nov 2015 → 05 Nov 2015
[ID=699170] Haut de la page
 LieuPhoenix, États-Unis
 Résumé Each fall since 1950, the American Association for Laboratory Animal Science has held its annual National Meeting. During the five days of the meeting, members and nonmembers come together to enjoy the workshops, lectures, poster sessions, and exhibits. The program is designed to have topics relevant to the entire membership. Exhibitors have an opportunity to interact with AALAS members from the academic community, research institutions, government organizations, and commercial companies. The AALAS National Meeting is the largest gathering in the world of professionals concerned with the production, care, and use of laboratory animals.
 Page web
 Sujets apparentés Essais cliniques; Législation en médecine et pharmacologie
9.Vaccines R&D-2015 — International Conference on Vaccines Research & Development
 Dates 02 Nov 2015 → 04 Nov 2015
[ID=679438] Haut de la page
 LieuBaltimore, États-Unis
 Résumé United Scientific Group welcomes International Conference on Vaccines Research & Development (Vaccines R&D-2015) in Baltimore, USA during November 02-04, 2015.

The Conference aims at bringing together professors, researchers, scientists, academicians and other professionals in vaccine community to exchange and discuss their original research results, practical development experiences, technological achievements and new ideas for developing future vaccines.

The meeting features highly informative and interactive sessions to encourage the exchange of ideas across a broad range of disciplines including the latest vaccine technologies, product development initiatives being used to develop new or improved vaccines.

 Sujets Basic vaccinology, Influenza vaccines/virus, Ebola outbreak, Vaccines discovery development & formulation, Novel vaccines, New vaccine adjuvants, Clinical trials, Emerging infectious diseases, Passive vaccines-therapeutic antibodies against infectious diseases, HIV/AIDS vaccines, Immunoinformatics, Cancer vaccines, HPV vaccines
 Page web
10.CSDD 2015 — International conference on Clinical Sciences and Drug Discovery
 Dates 02 Nov 2015 → 04 Nov 2015
[ID=731654] Haut de la page
 LieuBaltimore, Maryland, États-Unis
 Résumé Clinical Sciences and Drug Discovery-2015 (CSDD-2015) has been designed to have an insight on the drug discovery and targeted drug delivery systems. It is important that the professionals should meet up on regular basis to interact, network and exchange ideas and concepts. It is only by sharing ideas we develop new one that catalyze technological advancement. This conference is all set to bring together the global industry leaders, policy makers, innovators, public health researchers, pharmaceutical scientists, internists and primary care physicians together on one platform discussing the new opportunities in the transition
 Sujets Drug designing, Drug discovery, CNS drug discovery, Cancer targeted drug delivery, Cardiovascular drug discovery, Biomarkers, Biologics, Biopharmaceuticsls, small molecules, Adjuvants, Anti-infectives, Pharmacokinetics, Analytical sciences, Medicinal Chemistry, Medical Imaging, Computer Aided Drug Designing, Clinical trials, Drug efficacy, Toxicology
 Page web
 Contact Organizing Secretary CSDD 2015; Tél.: [408-426-4833]; Email.:
 Sujets apparentés Essais cliniques; Biochimie et chimie médicale, toxicologie
11.Vaccines Against Antigenically Variable Viruses
 Dates 05 Nov 2015 → 08 Nov 2015
[ID=702427] Haut de la page
 LieuAmes, États-Unis
 Page web
12.FAST: Functional Analysis & Screening Technologies Congress
 Dates 09 Nov 2015 → 11 Nov 2015
[ID=742688] Haut de la page
 LieuBoston, États-Unis
 Résumé CHI's FAST Congress brings you the latest technologies and research in cellular screening. The Third Annual Phenotypic Drug Discovery meeting will return with new updates and case studies in phenotypic screening, high-content analysis, physiologically-relevant cellular models, chemical genomics and chemical proteomics. The rapidly evolving area of 3D cellular models will be addressed by two back-to-back meetings, with the Inaugural 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models meeting focusing on the new predictive cellular models for drug discovery and toxicity assessment. It will review the use of primary and stem cells, complex co-culture cell models, tumor spheroid models, novel organ-on-a-chip models for efficacy and safety screening, functional analysis, and compound profiling. The Third Annual Screening and Functional Analysis of 3D Models meeting will follow with case studies of phenotypic and high-content screening of complex 3D cellular systems for compound and target selection
 Sujets tissue models, 3D tissue models, bioprinting, phenotypic drug discovery, organ-on-a-chip, human chips, toxicology, 3D spehroid, 3D culture, in vitro drug discovery
 Page web
 Contact James Prudhomme; Tél.: [781-972-5400]; Email.:
13.SCN — Functional Analysis & Screening Technologies Congress
 Dates 09 Nov 2015 → 11 Nov 2015
[ID=743609] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Cambridge Healthtech Institute (CHI) is pleased to announce the Third Annual FAST: Functional Analysis and Screening Technologies Congress. Now in its third year, the FAST Congress brings you the latest technologies and research in cellular screening.
 Sujets Organoids and Primary Organotypic 3D Culture in Drug Discovery, Phenotypic Screening for New Target, Pathway and Mechanism-of-Action Discovery, Phenotypic Screening Using Primary and Stem Cell-Derived Models, Case Studies in Phenotypic Drug Discovery, Engineering Functional Organ-on-a-Chip Models, 3D Spheroid Models for Drug Screening Integrated Approach to in vitro Drug Discovery: Tissue Engineering Meets Systems Biology, Microengineered 3D Models for Drug Safety Testing, Phenotypic and High-Content Screening of 3D Models, Cancer-on-a-Chip: Engineering 3D Models of Tumor Microenvironment
 Page web
 Contact Tél.: [(7819725400)]; Email.:
 Sujets apparentés Biotechnologie
14.2015 NEI Psychopharmacology Congress
 Dates 12 Nov 2015 → 15 Nov 2015
[ID=699190] Haut de la page
 LieuOrlando, États-Unis
 Page web
15.3rd Steroid Research Congress
 Dates 15 Nov 2015 → 18 Nov 2015
[ID=683476] Haut de la page
 LieuChicago, États-Unis
 Résumé As with previous successful meetings in the series this conference will bring together international delegates to address state-of-the-art approaches in the molecular basis of steroid-related common human diseases. The program will reflect the interdisciplinary nature of steroid research, involving aspects of analytics, chemistry, biology, medicine, bioinformatics and drug discovery.
 Page web
 Sujets apparentés Biologie; Endocrinologie
16.Biosimilars and Biobetters USA
 Dates 16 Nov 2015 → 17 Nov 2015
[ID=735075] Haut de la page
 LieuIselin, États-Unis
 Résumé Through a series of panel discussions, presentations and workshops, Biosimilars & Biobetters USA 2015 will offer effective strategies and solutions for developing cost effective biosimilars for the future. With an in-depth focus on the current and future landscape of the biosimilars market, this year's conference will allow input from key industry experts in the field to engage in meaningful and important discussions on how to accelerate drug development to market.
 Page web
17.CHI's Immunogenicity and Bioassay Summit 2015
 Dates 17 Nov 2015 → 19 Nov 2015
[ID=742656] Haut de la page
 LieuBaltimore, États-Unis
 Résumé The summit features opportunities for attendees to gain up-to-the-minute, implementable intelligence to overcome immunogenicity and bioassay challenges. The summit also includes more than 45 sessions, 4 dinner short courses, 12 roundtable breakouts and panel discussions, and an exhibit/poster hall showing the latest solutions. The summit is organized into 3 tracks: Immunogenicity Assessment & Clinical Relevance, Immunogenicity Prediction & Mitigation, and Optimizing Bioassays for Biologics.
 Sujets immunogenicity, bioassays, biologics, biosimilars, biotherapeutics, immune response, B and T cell epitopes, bioanalytical development
 Page web
 Contact James Prudhomme; Tél.: [7819725400]; Email.:
 Sujets apparentés Biologie
18.Therapeutic Area Partnerships 2015
 Dates 18 Nov 2015 → 20 Nov 2015
[ID=735160] Haut de la page
 LieuBoston, États-Unis
 Résumé Therapeutic Area Partnerships is a uniquely efficient gathering bringing together decision-makers to assess the most promising drug programs available for partnering in Cardiovascular/Metabolic Diseases, Neuroscience, Anti-Inflammatory/Autoimmune Diseases, Oncology/Immuno Oncology, Infectious and Emerging Diseases, Advanced Therapies (Cell, Gene and Stem Therapies), Orphan and Rare Diseases, and Academic Technology Transfer.
 Page web
19.Genetic Rx Boston
 Date de début03 Dec 2015
[ID=699244] Haut de la page
 LieuBoston, États-Unis
 Résumé Genetic Rx will take place at Harvard Medical School and will bring together academics and key industry leaders to discuss the emergence of new genetic medicines as well as the treatment of patients with rare and ultra-rare genetic diseases.
 Page web
 Sujets apparentés Médecine (en général)
20.The Biomarker Conference
 Dates 10 Dec 2015 → 11 Dec 2015
[ID=732239] Haut de la page
 LieuOrlando, États-Unis
 Résumé At 'The Biomarker Conference' to be held on 10 - 11 December 2015 in Orlando, Florida, USA 150+ biomarker experts will be gathering to discuss emerging pathways and breakthroughs in biomarker discovery and successful validation in consort with the regulatory guidelines and evolving cost-effective technologies that can help increase success rates in novel biomarker discovery and approvals for clinical utility.
 Sujets florida, biomarker discovery, biomarker validation, biomarkers in clinical trials, companion diagnostics, biobank research, clinical oncology, preclinical safety, pharmacogenomics, pharmacogenetics, drug discovery, genomics, bio-informatics, personalized medicine, translational research, biomarkers toxicity, molecular informatics, biomarker imaging, epigenetics biomarkers, systems biology, december, usa, orlando, conferences, summit, expo, congress, Pfizer, Roche, Janssen Research & Development, Novartis Institutes For BioMedical Research, Astrazeneca, Merck Serono, Harvard Medical School, The Wistar Institute, National Cancer Institute, National Institutes Of Health, Moffitt Cancer Center
 Page web
 Contact Ajay Nimbalkar; Tél.: [+912067046816]; Email.:
 Sujets apparentés Génomique et bio-informatique
21.NGS Data Analysis and Informatics Conference
 Dates 10 Dec 2015 → 11 Dec 2015
[ID=732235] Haut de la page
 LieuOrlando, États-Unis
 Résumé Growing collaborations between organisations and increased NGS data sharing between locations has created a need for a more robust and secure data storage, analysis, access and integration system while ensuring high quality of the NGS data being produced. At the ‘NGS Data Analysis and Informatics Conference' to be held on 10 - 11 December 2015 in Orlando, Florida - USA we will be discussing strategies to accurately analyse and scale-up informatics for the data generated through the NGS technology while ensuring quality & scalability of the data.
 Sujets NGS, next generation sequencing, precision medicine, biomarkers, genome studies, drug discovery, clinical diagnosis, data analysis, computational biology
 Page web
 Contact Ajay Nimbalkar; Tél.: [((+912067046816))]; Email.:
 Sujets apparentés Génomique et bio-informatique; Biologie des systèmes
22.Novel Immunotherapeutics Summit
 Dates 25 Jan 2016 → 26 Jan 2016
[ID=738643] Haut de la page
 LieuSan Diego, États-Unis
 Résumé We invite you to GTCbio's Novel Immunotherapeutics Summit, which takes place on January 25 - 26, 2016 in San Diego, CA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below.
 Sujets Cytokines & Inflammation, Immunotherapeutics & Immunomonitoring, Immunogenicity & Immunotoxicity, Allergy, Asthma, & COPD
 Page web
 Contact Kristen Starkey; Tél.: [626-256-6405]; Email.:
 Sujets apparentés Maladies Infectieuses
23.LDN 2016 — The LDN 2016 AIIC Conference
 Dates 19 Fév 2016 → 21 Fév 2016
[ID=725358] Haut de la page
 LieuOrlando, États-Unis
 Résumé The LDN AIIC 2016 Conference is produced by the LDN Research Trust, a non-profit, Registered Charity dedicated to raising awareness as well as funding research and clinical trials of LDN as a treatment for Crohn's Disease, Colitis, Autism, IBS, Lupus, Fibromyalgia, Rheumatoid, Arthritis, Chronic Pain and other auto-immune diseases. The central role of the conference is to review, compare and contrast the most recent LDN-related data and treatments. It also offers compelling examples, experiences and case studies from many of the world’s leading experts, practitioners and patients who are using LDN to achieve positive, and in many cases, life-changing results.
 Sujets LDN, MS, Chrohns, Fibromyalgia, Chronic Pain, Autism, Colitis, ME/CFS
 Page web
 Contact Jim Warner; Tél.: [+1 770-663-8803]; Email.:
 Sujets apparentés Neurologie; Médecine (en général)
24.G Protein-Coupled Receptors: Structure, Signaling and Drug Discovery
 Dates 21 Fév 2016 → 25 Fév 2016
[ID=739975] Haut de la page
 LieuKeystone, États-Unis
 Résumé The field of G protein-coupled receptors has recently seen major advances in high-resolution structure determination, as well as the validation of novel paradigms of drug action, such as allosteric modulation and biased agonism, as likely universal mechanisms. These studies are opening new insights into the diversity of this receptor superfamily, teaching us new lessons in receptor functionality and hinting at novel avenues to investigate. At the same time, we are seeing exciting discoveries in GPCR intracellular signaling and physiology. The timing is right to bring together researchers in these different areas. This Keystone Symposia meeting will focus on the interplay between these discoveries and how they are being used to advance GPCR-based research toward improved clinical outcomes. 
 Page web
 Sujets apparentés Biologie moléculaire
25.Pharmacokinetics for Pharmaceutical Scientists Course
 Dates 29 Fév 2016 → 04 Mar 2016
[ID=725765] Haut de la page
 LieuSan Francisco, États-Unis
 Page web
26.HIV Vaccines
 Dates 20 Mar 2016 → 24 Mar 2016
[ID=740186] Haut de la page
 LieuOlympic Valley, États-Unis
 Résumé HIV Persistence: Pathogenesis and Eradication. The development of a safe and effective HIV vaccine remains a major global health priority and a complex problem to solve. Current efforts emphasize an ability to elicit systemic and mucosal antibody responses capable of preventing the acquisition of infection. Evidence from multiple passive transfer experiments in non-human primates, as well as from studies of immunologic correlates of modest efficacy in the RV144 Thai trial, support the notion that both neutralizing and non-neutralizing antibodies have potential to prevent infection. Major advances have been made in understanding the epitopes, structures and evolutionary pathways of broadly neutralizing antibodies, leading to new avenues to pursue for vaccine design. The extraordinary breadth and potency of some recently discovered neutralizing antibodies has generated additional interest in potential therapeutic applications, including cure strategies. There has also been a steady increase in knowledge of other types of antiviral antibodies and their effector functions that may be important for vaccines. This meeting aims to cover a range of topics including: 1) Initial virus transmission events for vaccine intervention, 2) Non-neutralizing antibody correlates of sterilizing immunity; 3) Epitopes, structures and ontogeny of broadly neutralizing antibodies; 4) Novel vaccine concepts for broadly neutralizing antibody induction; and 5) Immunotherapy. Emphasis will be placed on recent unpublished findings in key areas that hold the greatest promise for rapid progress toward an effective vaccine.
 Page web
 Sujets apparentés Maladies Infectieuses
27.Biomarker Summit 2016
 Dates 21 Mar 2016 → 23 Mar 2016
[ID=744523] Haut de la page
 LieuSan Diego, États-Unis
 Résumé The Biomarker Summit 2016, to be held on March 21-23, 2016 in San Diego, CA at the Westin San Diego Hotel
 Sujets Oncology Biomarkers, Neurological Biomarkers, Inflammatory & Immunological Biomarkers
 Page web
 Contact Kristen Starkey; Tél.: [6262566405]; Email.:
 Sujets apparentés Biologie; Cancérologie
28.Biomarker Summit
 Dates 21 Mar 2016 → 23 Mar 2016
[ID=744896] Haut de la page
 LieuSan Diego, États-Unis
 Résumé The Biomarker Summit is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization. A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments.
 Page web
29.Modern Phenotypic Drug Discovery: Defining the Path Forward
 Dates 02 Avr 2016 → 06 Avr 2016
[ID=743856] Haut de la page
 LieuBig Sky, États-Unis
 Résumé Innovation and productivity in pharmaceutical drug discovery have been below expectations. Surprisingly, more first-in-class small molecule drugs approved by the FDA (1999-2008) were identified by functional approaches reminiscent of pre-genomics pharmacology (phenotypic drug discovery) than by contemporary molecular targeted strategies. This observation, and the unexpected difficulties of target validation, have diminished the impact of the “genomics revolution” and are arguably associated with the decline in innovation and productivity of pharmaceutical research. As a result, pharmaceutical researchers have begun to reevaluate the “Molecular Mindset” which has dominated our collective drug-hunting culture, and explore modern approaches to phenotypic screening. However, there is currently no single scientific forum where scientists from pharma, biotech, academia and instrument/service providers can meet and discuss strategies/issues related to phenotypic drug discovery (PDD). In part, this is because PDD encompasses multiple therapeutic areas and involves diverse disciplines including drug discovery, chemistry, cell biology, stem cell biology, systems biology, genomics, bioengineering and informatics. This Keystone Symposia meeting uniquely provides this interdisciplinary environment and is a particularly attractive venue given the increasing role of academia in drug discovery research. The conference will be a forum for the global PDD research community in which scientists from diverse institutions and scientific disciplines can meet to share/discuss/debate topics related to advantages/disadvantages of PDD and how PDD can complement targeted approaches. Significantly, the conference will provide a much needed forum for the growing interest in PDD, and can conceivably become the cornerstone of the global scientific movement for the reintroduction of functional biology/physiology-driven pharmaceutical research.
 Page web
 Sujets apparentés Biologie moléculaire
30.New Therapeutics for Diabetes and Obesity
 Dates 17 Avr 2016 → 20 Avr 2016
[ID=743903] Haut de la page
 LieuLa Jolla, États-Unis
 Résumé Type 2 diabetes (T2DM) is a global pandemic with approximately 350 million patients worldwide, driven largely by increasing prevalence of obesity. Multiple options exist for treatment of the primary disease and the array of associated cardiovascular disorders. Nonetheless, the majority of patients do not reach recommended glycemic goals, and there is an urgent need for more efficacious, cost-effective and safe therapies. The regulatory hurdle for new drugs is sizable and challenged by the specific requirement for cardiovascular mortality study. Given the magnitude of the challenges, highly collaborative efforts involving academia, biotech, pharma, regulatory agencies, patient advocacy groups and other key stakeholders are required to identify and advance new therapies that are substantially differentiated from current disease management. The major goals of this meeting are to: 1) Define the distance between current therapy relative to what is most needed to address successfully the near-term challenges of the disease and the wave of later-stage disease-specific complications; 2) Communicate the most important scientific advances in metabolic diseases with the intimate details that often escape peer-review publication and are seminal to drug R&D; and 3) Create opportunities for candid discussion among key stakeholders (academia, biotech, industry, regulatory, venture community, etc.) to identify new business processes, along with new science to streamline the successful conversion of ideas to medicines. Is it anticipated that the perspectives and science presented at this meeting, together with multiple platforms for discussion and interaction, will facilitate the identification of collaborations and opportunities for the discovery of transformative treatment of diabetes and related disorders. The meeting will be uniquely led by experienced drug-hunters with world-class academic credentials to help foster the translation of basic science to breakthrough therapeutics. We anticipate that this meeting will be of interest to a broad and diverse group of individuals interested in drug discovery and cost-effective development with an emphasis on quality, speed and value.
 Page web
 Sujets apparentés Endocrinologie
31.World Orphan Drug Congress USA 2016
 Dates 20 Avr 2016 → 22 Avr 2016
[ID=728925] Haut de la page
 LieuWashington, DC, États-Unis
 Résumé This is the largest global industry gathering for the orphan drug industry and rare disease community where pharma, biotech, patient groups, academia, regulators, payers and investors gather to talk about strategies to expedite orphan drug development. We grew the event to 600 participants in 2015 with over 25 countries represented. cademic medical centers, HCPs, clinicians and point of care diagnostics will be a new focus in 2016. Specific orphan products and their Marketing Managers will also be a stronger focus along with gene therapy as the future rare disease cure. Meet CEOs, VPs and Directors of the following business units from pharma and biotech: R&D, Business Development, Regulatory Access, Market Access, Commercial, Marketing and Brand/Product Managers.You will also meet Scientists, Investigators and Engineers as well as relevant Heads from university departments studying rare disease and developing a cure.
 Sujets In terms of content, people are talking more and more about gene therapy orphan drugs. 2016 will feature the latest content on gene therapy orphan drugs in development. The other new addition to 2016 is a workshop for clinicians. This workshop is designed to enable marketers to help clinicians get educated on rare diseases and orphan drugs so they can detect and diagnose rare diseases better and faster.
 Page web Service&utm_medium=Listing&utm_campaign=COMSListing
 Contact Freya Smale; Tél.: [646-619-1811]; Email.:

États-Unis: liste de tous les évènements/conférences.

Dernière mise à jour: 20 septembre 2015